Impact of Plasma Glucose Level at the Time of Fluorodeoxyglucose Administration on the Accuracy of FDG-PET/CT in the Diagnosis of Pancreatic Lesions

Authors Information
Article Notes and Dates
To Cite : Hamidian Jahromi A, Fallahzadeh M K, Takalkar A, Sheng J, Zibari G, et al. Impact of Plasma Glucose Level at the Time of Fluorodeoxyglucose Administration on the Accuracy of FDG-PET/CT in the Diagnosis of Pancreatic Lesions, Int J Endocrinol Metab. 2014 ;12(4):e16429. doi: 10.5812/ijem.16429.
Copyright: Copyright © 2014, International Journal of Endocrinology and Metabolism. .
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Grassetto G, Rubello D. Role of FDG-PET/CT in diagnosis, staging, response to treatment, and prognosis of pancreatic cancer. Am J Clin Oncol. 2011; 34(2): 111-4[DOI][PubMed]
  • 2. Asagi A, Ohta K, Nasu J, Tanada M, Nadano S, Nishimura R, et al. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. Pancreas. 2013; 42(1): 11-9[DOI][PubMed]
  • 3. De Gaetano AM, Rufini V, Castaldi P, Gatto AM, Filograna L, Giordano A, et al. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors. Abdom Imaging. 2012; 37(6): 983-1003[DOI][PubMed]
  • 4. Janssen MH, Ollers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, et al. Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer. Radiother Oncol. 2010; 95(2): 203-8[DOI][PubMed]
  • 5. Chang YC, Yen TC, Ng KK, See LC, Lai CH, Chang TC, et al. Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer? Eur J Nucl Med Mol Imaging. 2005; 32(6): 647-52[DOI][PubMed]
  • 6. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer--a PET study. J Nucl Med. 1993; 34(1): 1-6[PubMed]
  • 7. Diederichs CG, Staib L, Vogel J, Glasbrenner B, Glatting G, Brambs HJ, et al. Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas. 2000; 20(2): 109-16[PubMed]
  • 8. Caobelli F, Pizzocaro C, Paghera B, Guerra UP. Proposal for an optimized protocol for intravenous administration of insulin in diabetic patients undergoing (18)F-FDG PET/CT. Nucl Med Commun. 2013; 34(3): 271-5[DOI][PubMed]
  • 9. Ong LC, Jin Y, Song IC, Yu S, Zhang K, Chow PK. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II. Acta Radiol. 2008; 49(10): 1145-53[DOI][PubMed]
  • 10. Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, et al. Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading. Nucl Med Commun. 2002; 23(6): 545-50[PubMed]
  • 11. Khan N, Islam MM, Mahmood S, Hossain GA, Chakraborty RK. 18F-fluorodeoxyglucose uptake in tumor. Mymensingh Med J. 2011; 20(2): 332-42[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check